MedPath

Comparison of Silicone-covered Metallic Ureteral Stent and Double-J Stent for Malignant Ureteral Obstruction

Phase 2
Conditions
Malignant Ureteral Obstruction
Interventions
Device: Silicone-covered metallic stent
Device: Double-J stent
Registration Number
NCT01823575
Lead Sponsor
Asan Medical Center
Brief Summary

Malignant ureteral obstruction often necessitates chronic urinary diversion and is associated with high rates of failure with traditional double-J ureteral stents. To overcome drawbacks of the double-J stent, recently, metallic stents have been used to manage for palliative treatment in patients with ureteral obstruction associated with end stage malignant disease. The success rates of metallic stents have been reported to be high and the method proved to be useful in patients with malignant ureteral obstruction. In addition, covered metallic stents have many advantages compared with bare metallic stents, such as lower rate of tissue invasion and higher patency rate. However, there is little investigation about comparison of clinical efficacy between covered-metallic stents and double-J stents in malignant ureteral obstruction.

Therefore, investigators plan to perform a prospective randomized study to compare clinical efficacy of silicone-covered metallic ureteral stent and double-J ureteral stent in patients with malignant ureteral obstruction.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
78
Inclusion Criteria
  1. Age 20-80 years
  2. Malignant mid- to distal ureteral obstruction by abdominal or pelvic malignancy with overt hydronephrosis documented on CT scans
  3. Expected life expectancy more than three months
Exclusion Criteria
  1. History of unilateral nephrectomy or bladder reconstruction
  2. History of kidney transplantation
  3. History of severe allergy to contrast media
  4. State of dialysis
  5. Performance status - 3 or 4 on ECOG scale

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Silicone-covered metallic ureteral stentSilicone-covered metallic stentDeployment of a silicone-covered metallic ureteral stent for malignant ureteral obstruction and compare the results with placement of a double-J stent in terms of primary patency rate at 3 month follow-up (primary end point)
Double-J stentDouble-J stentPlacement of a double-J stent for malignant ureteral obstruction and compare these results to deployment of a silicone-covered metallic stent in terms of primary patency rate at 3 month follow-up.
Primary Outcome Measures
NameTimeMethod
primary patency rate at 3-month F.U.3 month after stent deployment

Confirmation of patency of the stents with USG and renal biochemistry, without additional intervention.

Secondary Outcome Measures
NameTimeMethod
Primary patency rate at 6- and 12-month F.U.at 6 and 12 months after stent deployment

Confirmation of patency of the stents with USG and renal biochemistry, without additional intervention.

Assessment of complications in two study groups.

Trial Locations

Locations (1)

Asan Medical Center

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath